Impaired in vivo vasculogenic potential of endothelial progenitor cells in comparison to human umbilical vein endothelial cells in a spheroid-based implantation model

Cell Proliferation

Volumn 42, Issue 4, 2009, Pages 498-505

  Finkenzeller, G ^a   Graner, S ^a   Kirkpatrick, C J ^b   Fuchs, S ^b   Stark, G B ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CADHERIN; CD31 ANTIGEN; MATRIGEL; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PROTEIN EXPRESSION; SPHEROID CELL; TISSUE ENGINEERING; UMBILICAL VEIN; XENOGRAFT;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MICE; MICE, SCID; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; SPHEROIDS, CELLULAR; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; TRANSPLANTATION, HETEROLOGOUS; UMBILICAL VEINS;

MUS;

EID: 67649848199     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2009.00610.x     Document Type: Article

References (34)

1. Shieh SJ, Vacanti JP (2005) State-of-the-art tissue engineering: from tissue engineering to organ building. Surgery 137, 1-7.
2. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K et al. (1998) Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 91, 1114-1123.
3. Schumacher B, Pecher P, von Specht BU, Stegmann T (1998) Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 91, 645-650.
4. Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M et al. (2001) Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am. Heart J. 142, 872-880.
5. Scheduler JS, Nath AK, Zheng L, Kluger MS, Hughes CC, Sierra-Honigmann MR et al. (2000) In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc. Natl. Acad. Sci. USA 91, 9191-9196.
6. Koike N, Fukumura D, Gralla O, Au P, Scheduler JS, Jain RK (2004) Tissue engineering: creation of long-lasting blood vessels. Nature 428, 138-139.
7. Alajati A, Laib AM, Weber H, Boos AM, Bartol A, Ikenberg K et al. (2008) Spheroid-based engineering of a human vasculature in mice. Nat. Methods 5, 439-445.
8. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
9. Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M et al. (2001) Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp. Med. 193, 1005-1014.
10. Heeschen C, Aicher A, Lehmann R, Fichtischerer S, Vasa M, Urbich C et al. (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102, 1340-1346.
11. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705.
12. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H et al. (2001) Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103, 634-637.
13. Fuchs S, Hermanns MI, Kirkpatrick CJ (2006) Retention of a differentiated endothelial phenotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures. Cell Tissue Res. 326, 79-92.
14. Finkenzeller G, Torio-Padron N, Momeni A, Mehlhorn AT, Stark GB (2007) In vitro angiogenesis properties of endothelial progenitor cells: a promising tool for vascularization of ex vivo engineered tissues. Tissue Eng. 13, 1413-1420.
15. Siemeister G, Schirner M, Reusch P, Barleon B, Marme D, Martiny-Baron G (1998) An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc. Natl. Acad. Sci. USA 95, 4625-4629.
16. Korff T, Augustin HG (1998) Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol. 143, 1341-1352.
17. Sieminski AL, Hebbel RP, Gooch KJ (2005) Improved microvascular network in vitro by human blood outgrowth endothelial cells relative to vessel-derived endothelial cells. Tissue Eng. 11, 1332-1345.
18. Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Konane DS, Darland DC et al. (2005) Engineering vascularized skeletal muscle tissue. Nat. Biotechnol. 23, 879-884.
19. Darland DC, D'Amore PA (2001) TGFβ is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/ 2 and endothelial cells. Angiogenesis 4, 11-20.
20. Carmeliet P (2003) Angiogenesis in health and disease. Nat. Med. 9, 653-660.
21. Jain RK (2003) Molecular regulation of vessel maturation. Nat. Med. 9, 685-693.
22. Korff T, Augustin HG (1999) Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci. 112, 3249-3258.
23. Abramsson A, Lindblom P, Betsholtz C (2003) Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin. Invest. 112, 1142-1151.
24. Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C (1999) Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel
25. formation in the mouse. Development 126, 3047-3055.
26. Kobayashi H, DeBusk LM, Babichev YO, Dumont DJ, Lin PC (2006) Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment. Blood 108, 1260-1266.
27. Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM et al. (2008) Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 111, 1302-1305.
28. Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J (2007) In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109, 4761-4768.
29. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L et al. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Methods 1, 1194-1201.
30. Göthert JR, Gustin SE, van Eekelen JA, Schmidt U, Hall MA, Jane SM et al. (2004) Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 104, 1769-1777.
31. De Palma M, Venneri MA, Roca C, Naldini L (2003) Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9, 789-795.
32. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N et al. (2002) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCAREAMI). Circulation 106, 3009-3017.
33. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK et al. (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vase. Biol. 24, 288-293.
34. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107, 1164-1169.